Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

AZ505

AZ505 is a potent and selective SMYD2 inhibitor with an IC50 of 0.12 μM.

Product Specifications

CAS Number

1035227-43-0

UNSPSC

12352005

Hazard Statement

H302, H315, H319, H335

Target

Histone Methyltransferase

Type

Reference compound

Related Pathways

Epigenetics

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/az505.html

Purity

99.99

Solubility

DMSO : ≥ 135 mg/mL

Smiles

O=C(N(C1CCCCC1)CCNCCC2=C(OCC(N3)=O)C3=C(O)C=C2)CCNCCC4=CC=C(Cl)C(Cl)=C4

Molecular Formula

C29H38Cl2N4O4

Molecular Weight

577.54

Precautions

H302, H315, H319, H335

References & Citations

[1]Komatsu S, et al. Overexpression of SMYD2 contributes to malignant outcome in gastric cancer. Br J Cancer. 2015 Jan 20;112 (2) :357-64.|[2]Ferguson AD, et al. Structural basis of substrate methylation and inhibition of SMYD2. Structure. 2011 Sep 7;19 (9) :1262-73.|[3]Li LX, et al. Lysine methyltransferase SMYD2 promotes cyst growth in autosomal dominant polycystic kidney disease. J Clin Invest. 2017 Jun 30;127 (7) :2751-2764.

Shipping Conditions

Blue Ice

Storage Conditions

-20°C, 3 years (Powder)

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Isoform

SMYD2

Citation 01

Am J Physiol Renal Physiol. 2022 Aug 1;323 (2) :F227-F242.|Biochem Pharmacol. 2026 Jan;243 (Pt 2) :117562.|Biomedicines. 2024 Oct 8;12 (10) :2279.|Cell Death Dis. 2018 Feb 27;9 (3) :326.|Cell Death Dis. 2021 May 2;12 (5) :439.|Cell Death Dis. 2022 Jan 12;13 (1) :52.|Cell Death Discov. 2022 Jun 6;8 (1) :274.|Cell. 2023 Apr 27;186 (9) :1968-1984.e20.|Cells. 2022 Apr 8;11 (8) :1262.|Clin Exp Pharmacol Physiol. 2025 Jul;52 (7) :e70035.|FASEB J. 2021 Jul;35 (7) :e21715.|J Bone Metab. 2021 Nov;28 (4) :297-305.|J Clin Invest. 2017 Jun 30;127 (7) :2751-2764.|Mol Carcinog. 2023 Aug;62 (8) :1119-1135.|Oncogene. 2021 Apr;40 (15) :2711-2724.|Research Square Preprint. 2021 Oct.|Sci Adv. 2020 Oct 30;6 (44) :eabb3154.|Sci Adv. 2023 Jun 16;9 (24) :eade6624.|Theranostics. 2019 Oct 22;9 (26) :8377-8391. |Development. 2020 Sep 28;147 (18) :dev190678.|Exp Cell Res. 2021 Jul 15;404 (2) :112649.|Mol Carcinog. 2023 Jul;62 (7) :940-950.

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

ZNF500 Mouse Monoclonal Antibody (HRP conjugated) [Clone ID: OTI1H2]
TA803351BM 100 µL

ZNF500 Mouse Monoclonal Antibody (HRP conjugated) [Clone ID: OTI1H2]

Sign In for Pricing
View Details
BXDC2 (BRIX1) Rabbit Polyclonal Antibody
TA374085 100 µL

BXDC2 (BRIX1) Rabbit Polyclonal Antibody

Sign In for Pricing
View Details
Frozen Tissue Sections, Brain
CS629815 5x 5 µm

Frozen Tissue Sections, Brain

Sign In for Pricing
View Details
TM4SF2 (TSPAN7) (NM_004615) Human Over-expression Lysate
LY401460 100 µg

TM4SF2 (TSPAN7) (NM_004615) Human Over-expression Lysate

Sign In for Pricing
View Details
N-Caproic Acid Isopropyl Ester
TRC-C175748-250MG 250 mg

N-Caproic Acid Isopropyl Ester

Sign In for Pricing
View Details
CD53 (161-2), CF405S conjugate, 0.1mg/mL
BNC040324-500 1x 500 µL

CD53 (161-2), CF405S conjugate, 0.1mg/mL

Sign In for Pricing
View Details